Susquehanna International Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
594,288
+345,643
| +139% | +$1.19M | ﹤0.01% | 2264 |
|
|
2025
Q1 | $554K | Sell |
248,645
-168,751
| -40% | -$376K | ﹤0.01% | 4208 |
|
|
2024
Q4 | $1.22M | Buy |
417,396
+183,332
| +78% | +$537K | ﹤0.01% | 2696 |
|
|
2024
Q3 | $609K | Sell |
234,064
-14,684
| -6% | -$38.2K | ﹤0.01% | 3375 |
|
|
2024
Q2 | $736K | Buy |
248,748
+26,690
| +12% | +$79K | ﹤0.01% | 2956 |
|
|
2024
Q1 | $1.01M | Sell |
222,058
-113,934
| -34% | -$516K | ﹤0.01% | 2648 |
|
|
2023
Q4 | $1.92M | Buy |
335,992
+95,767
| +40% | +$547K | ﹤0.01% | 1997 |
|
|
2023
Q3 | $1.11M | Sell |
240,225
-298,781
| -55% | -$1.37M | ﹤0.01% | 2450 |
|
|
2023
Q2 | $3.48M | Buy |
539,006
+385,667
| +252% | +$2.49M | ﹤0.01% | 1380 |
|
|
2023
Q1 | $1.16M | Sell |
153,339
-12,770
| -8% | -$96.3K | ﹤0.01% | 2683 |
|
|
2022
Q4 | $1.68M | Buy |
166,109
+106,065
| +177% | +$1.07M | ﹤0.01% | 1751 |
|
|
2022
Q3 | $594K | Buy |
+60,044
| New | +$594K | ﹤0.01% | 3293 |
|
|
2022
Q2 | – | Sell |
-128,512
| Closed | -$1.25M | – | 5722 |
|
|
2022
Q1 | $1.25M | Sell |
128,512
-285,901
| -69% | -$2.79M | ﹤0.01% | 2547 |
|
|
2021
Q4 | $5.93M | Sell |
414,413
-19,967
| -5% | -$286K | ﹤0.01% | 1074 |
|
|
2021
Q3 | $8.71M | Buy |
434,380
+201,554
| +87% | +$4.04M | ﹤0.01% | 833 |
|
|
2021
Q2 | $5.12M | Buy |
232,826
+162,626
| +232% | +$3.58M | ﹤0.01% | 1253 |
|
|
2021
Q1 | $2.38M | Buy |
70,200
+49,105
| +233% | +$1.67M | ﹤0.01% | 1907 |
|
|
2020
Q4 | $849K | Buy |
+21,095
| New | +$849K | ﹤0.01% | 2785 |
|